The coronavirus pandemic has led to severe shortages of personal protective equipment (PPE) needed to protect Americans from the disease. The crisis has revealed an overreliance on imported supplies, particularly from China.

Robert Eubanks, director of healthcare and life sciences with West Monroe, discuses the changes in how vaccines and drug therapies are developed and distributed as a result of the COVID-19 pandemic.

David Rejeski, visitor scholar at the Environmental Law Institute, describes efforts to obtain objective information about the “green” impacts of technological innovations such as blockchain, platform sharing and artificial intelligence.

Michael Sandonato, partner in the law firm of Venable LLP, describes a bill in the House of Representatives to prevent patent trolls from using the International Trade Commission to extort royalty payments.

A panel discussion focusing on the latest changes in rules and regulations governing U.S. exports, both at origin and destination.

Phil Renaud, executive director of The Risk Institute at The Ohio State University’s Fisher College of Business, runs down the level of risk to supply chains created by relationships with third parties — and relates how a certain type of third party can help to mitigate it.